FENNEC PHARMACEUTICALS INC. (FENC) Form 10-K Annual Reports
FENNEC PHARMACEUTICALS INC. (FENC) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FENC
CIK: 1211583
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerRichard Smetanka
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0002043395-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001926254-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0002043317-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0002043411-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001468308-26-000034 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 Filing | 0002043395-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 Filing | 0002043317-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 Filing | 0001926254-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 Filing | 0002043411-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | 4 Filing | 0001468308-26-000032 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-17 | 8-K | 0001104659-26-108565 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | 4 Filing | 0001589776-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009471 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008901 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-31 | 4 Filing | 0001468316-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | 4 Filing | 0002043395-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | 4 Filing | 0002043317-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | 4 Filing | 0002043411-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | 4 Filing | 0001926254-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-31 | 4 Filing | 0001468308-26-000030 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001950047-26-008849 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-27 | 4 Filing | 0001468308-26-000028 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001950047-26-008768 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001012975-26-000770 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001604867-26-000013 | View SEC Doc Filr Page |